SCHEMBL6223147

SCHEMBL6223147

OCCC1NCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6221349 0.82
SCHEMBL9575649 0.79 CYP2D6 (0.30)
SCHEMBL2709591 0.77
SCHEMBL6220571 0.73
SCHEMBL15148056 0.69
SCHEMBL8463736 0.69 AGL (0.39)
SCHEMBL7025164 0.69
SCHEMBL4719059 0.69
SCHEMBL30876713 0.67
SCHEMBL6800885 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6846827-B1 Pyrimidine derivatives ASTRAZENECA AB (SE) 2005-01-25 US claimed
EP-1226126-B1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2005-01-05 EP claimed
EP-1226126-A1 PYRIMIDINE DERIVATIVES AstraZeneca AB (SE) 2002-07-31 EP claimed
WO-2001027089-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2001-04-19 WO claimed
EP-1002824-B1 AMINATED POLYSILAZANE AND PROCESS FOR THE PREPARATION THEREOF AZ ELECTRONIC MATERIALS USA (US) 2005-11-09 EP disclosed
US-6846827-B1 Pyrimidine derivatives ASTRAZENECA AB (SE) 2005-01-25 US disclosed
EP-1226126-B1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2005-01-05 EP disclosed
EP-1226126-A1 PYRIMIDINE DERIVATIVES AstraZeneca AB (SE) 2002-07-31 EP disclosed
US-6310168-B1 POLYSILAZANES WITH OXY PENDANT GOUPS TONEN CORPORATION (JP) 2001-10-30 US disclosed
WO-2001027089-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2001-04-19 WO disclosed
EP-1002824-A1 AMINATED POLYSILAZANE AND PROCESS FOR THE PREPARATION THEREOF Tonen Corporation (JP) 2000-05-24 EP disclosed